CR9103A - LACTAMA COMPOUNDS AND THEIR USES AS PHARMACEUTICS - Google Patents
LACTAMA COMPOUNDS AND THEIR USES AS PHARMACEUTICSInfo
- Publication number
- CR9103A CR9103A CR9103A CR9103A CR9103A CR 9103 A CR9103 A CR 9103A CR 9103 A CR9103 A CR 9103A CR 9103 A CR9103 A CR 9103A CR 9103 A CR9103 A CR 9103A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compounds
- lactama
- pharmaceutics
- diseases associated
- dehydrogenase type
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000002395 mineralocorticoid Substances 0.000 abstract 2
- 102000004277 11-beta-hydroxysteroid dehydrogenases Human genes 0.000 abstract 1
- 108090000874 11-beta-hydroxysteroid dehydrogenases Proteins 0.000 abstract 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 abstract 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 abstract 1
- 101710088194 Dehydrogenase Proteins 0.000 abstract 1
- 229960002478 aldosterone Drugs 0.000 abstract 1
- -1 hydroxyl steroid Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se refiere a inhibidores de 11-B hidroxil esteroide deshidrogenasa tipo 1, antagonistas del receptor mineralocorticoide (MR), y composiciones farmaceuticas de los mismos. Los compuestos de la invencion pueden ser utiles en el tratamiento de varias enfermedades asociadas con la expresion o actividad de 11-B hidroxil esteroide deshidrogenasa tipo 1 y/o enfermedades asociadas con exceso de aldosterona.The present invention relates to 11-B hydroxyl steroid dehydrogenase type 1 inhibitors, mineralocorticoid (MR) receptor antagonists, and pharmaceutical compositions thereof. The compounds of the invention may be useful in the treatment of various diseases associated with the expression or activity of 11-B hydroxy steroid dehydrogenase type 1 and / or diseases associated with excess aldosterone.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62661704P | 2004-11-10 | 2004-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9103A true CR9103A (en) | 2007-08-28 |
Family
ID=39012070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9103A CR9103A (en) | 2004-11-10 | 2007-05-03 | LACTAMA COMPOUNDS AND THEIR USES AS PHARMACEUTICS |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101098856A (en) |
| CR (1) | CR9103A (en) |
| UA (1) | UA93036C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102267995A (en) * | 2010-06-04 | 2011-12-07 | 艾琪康医药科技（上海）有限公司 | Method for preparing diazaspiro compound |
-
2005
- 2005-11-09 CN CNA2005800459986A patent/CN101098856A/en active Pending
- 2005-11-09 UA UAA200706357A patent/UA93036C2/en unknown
-
2007
- 2007-05-03 CR CR9103A patent/CR9103A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA93036C2 (en) | 2011-01-10 |
| CN101098856A (en) | 2008-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8901A (en) | AMIDO COMPOUNDS AND THEIR USES AS PHARMACEUTICS | |
| CR8702A (en) | AMIDO COMPOUNDS AND ITS USES AS PHARMACEUTICS | |
| CR8793A (en) | PIRIDINES REPLACED AND ITS USE AS PHARMACEUTICS | |
| ECSP067113A (en) | AMIDO COMPOUNDS AND ITS USE AS PHARMACEUTICALS | |
| CR9987A (en) | LACTAMA COMPOUNDS AND METHODS OF USE OF THE SAME | |
| CR8759A (en) | 3-AMINOCICLOPENTANOCARBOXAMIDS AS MODULATORS OF CHEMIOKIN RECEPTORS | |
| BRPI0518022A (en) | lactam compounds and their use as pharmaceuticals | |
| BRPI0512630A (en) | starch compounds and their use as pharmaceuticals | |
| MX2020002666A (en) | Anti- folate receptor alpha antibody conjugates and their uses. | |
| CR10243A (en) | "BENCIMIDAZOLES 2-REPLACED AS SELECTIVE ANDROGEN RECEPTOR MODULARS" | |
| SV2011003855A (en) | HETEROARILOS SUBSTITUTED | |
| CR8775A (en) | 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS | |
| CL2008003593A1 (en) | Isoxazolo-pyridazine derived compounds; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cognitive disorders such as Alzheimer's | |
| CL2011001263A1 (en) | Compounds derived from optionally substituted pyrimidinones; pharmaceutical composition that includes them; and its use as phosphodiesterase 1 (pde1) inhibitors for the treatment of diseases involving disorders of the intracellular trajectory of the dopamine d1 receptor such as parkinson's, Alzheimer's, depression, bipolar disease, hypertension, glaucoma. | |
| UY32968A (en) | FUSIONED HETEROCYCLIC COMPOUNDS AS OREXINE RECEIVER MODULATORS | |
| CO6300954A2 (en) | DERIVATIVES OF TIENOPIRIDINONES AS PROTEIN QUINASA ACTIVATORS ACTIVATED BY AMPK | |
| CR10060A (en) | 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS | |
| GT201000008A (en) | CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES AND THERAPEUTIC USE | |
| CL2009000445A1 (en) | Compounds derived from piperidine 1,4 heterocycle substituted, procedure to prepare these compounds, pharmaceutical composition comprising them and their use for pain therapy and the treatment of diseases such as Alzheimer's, schizophrenia, anxiety and depression. | |
| CR9722A (en) | DERIVATIVES OF BENZILPIPERAZINA AND ITS MEDICAL USE | |
| CR8745A (en) | 3- (4-HETEROARILCICLOHEXILMINO) CYCLOPENTACARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS | |
| CL2011000405A1 (en) | Polycyclic pyrazolyl n-sulfonamido derivatives; inhibitors of the release and synthesis of beta-amyloid and y-secretase peptides; pharmaceutical composition comprising them; and its uses in the treatment of Alzheimer's, Parkinson's, Down syndrome, among others. | |
| UY29245A1 (en) | MEDICAL COMBINATIONS | |
| CL2008003362A1 (en) | Heterocycles derived from thiene (2,3-d) pyrimidinone, with stimulating activity of the ampa receptor; pharmaceutical composition; and use of the compounds in the treatment of psychiatric conditions such as schizophrenia, depression, and learning disorders. | |
| UY29244A1 (en) | MEDICAL COMBINATIONS |